Julio Gagne
About Julio Gagne
Julio Gagne serves as the Vice President of Corporate Development at Kite Pharma, leading global program strategies for AML and solid tumor therapies. With over three decades of experience in the biotechnology and pharmaceutical sectors, he has held various strategic roles at notable companies, including Bristol-Myers Squibb, ImmunoGen, and Travere Therapeutics.
Current Role at Kite Pharma
Julio Gagne serves as the Vice President of Corporate Development at Kite Pharma, where he is the Global Program Lead for Acute Myeloid Leukemia (AML) and Solid Tumor Strategy. He has held this position since 2021, overseeing the strategic direction and development of therapies targeting these specific cancer types. His role involves coordinating cross-functional teams to ensure effective program execution and alignment with corporate objectives.
Previous Experience in Biotech and Pharmaceuticals
Julio Gagne has over three decades of experience in the biotechnology and pharmaceutical sectors. He has held various leadership roles in program management and corporate development across multiple organizations. His previous positions include Vice President of Program & Alliance Management at Travere Therapeutics, Executive Director of Program Management at ImmunoGen, and Head of Oncology & Immunoscience Portfolio at Bristol-Myers Squibb. His extensive background includes contributions to oncology portfolios and strategic leadership in drug development.
Educational Background
Julio Gagne earned a Bachelor of Arts in Biochemistry from the University of California, Berkeley. He furthered his education by obtaining a Master of Business Administration (MBA) in Finance from San Francisco State University. His educational qualifications provide a solid foundation for his career in the biotechnology and pharmaceutical industries.
Leadership in Oncology Development
Throughout his career, Julio Gagne has demonstrated expertise in leading global program strategies specifically for AML and solid tumor therapies. His roles have required strategic leadership and cross-functional collaboration, particularly in the development and management of oncology portfolios. He has a proven track record of working with leading pharmaceutical companies to advance therapeutic solutions in oncology.
Career Progression and Contributions
Julio Gagne's career includes significant contributions to various pharmaceutical companies, including Amgen, Onyx Pharmaceuticals, and Novartis Oncology. He has held key positions such as Senior Project Manager and Director of Project Management, where he contributed to the development of critical oncology therapies. His experience spans roles in program management, strategic marketing, and corporate development, emphasizing his versatility and depth of knowledge in the industry.